• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

R848 对曼氏血吸虫感染相关细胞因子产生的免疫调节作用。

Immunomodulatory effect of R848 on cytokine production associated with Schistosoma mansoni infection.

机构信息

Immunology Research Lab, Department of Microbiology and Immunology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.

出版信息

Parasitol Res. 2013 Jan;112(1):135-40. doi: 10.1007/s00436-012-3116-2. Epub 2012 Sep 20.

DOI:10.1007/s00436-012-3116-2
PMID:22992895
Abstract

This work aimed to determine the effect of resiquimod (R848), a low molecular weight imidazoquinolinamine compound with properties as immune response modifiers, on cytokine production in patients infected with Schistosoma mansoni with various degrees of hepatic fibrosis. Schistosoma-infected patients were classified into four groups according to the degree of hepatic fibrosis as examined by ultrasonography group 0 (no fibrosis), group I (incipient fibrosis), group II (moderate fibrosis), and group III (severe fibrosis). Levels of interferon-γ (IFN-γ), interleukin 4 (IL-4), IL-10, and IL-13 were measured by ELISA in the supernatants of cultured peripheral blood mononuclear cells (PBMC) in response to schistosoma egg soluble antigen (SEA) in the presence and absence of R848. R848 induced a significantly higher level of IL-10 in supernatants of SEA-stimulated PBMC of patients in all groups of hepatic fibrosis except group III. Moreover, we significantly found higher levels of IFN-γ in group 0 and group I and significantly lower level of IL-4 in group 0 after R848 stimulation. However, R848 had no effect on IL-13. Taken together, these results suggest that R848 might be used as an immunopotentiating agent in view of novel therapy or vaccine for S. mansoni infection.

摘要

本研究旨在探讨瑞喹莫德(R848)对不同程度肝纤维化曼氏血吸虫感染患者细胞因子产生的影响。瑞喹莫德是一种低分子量咪唑并喹啉胺化合物,具有免疫反应调节剂的特性。根据超声检查结果,将曼氏血吸虫感染患者分为 4 组:0 组(无纤维化)、I 组(早期纤维化)、II 组(中度纤维化)和 III 组(重度纤维化)。采用 ELISA 法检测 SEA 刺激 PBMC 培养上清液中 IFN-γ、IL-4、IL-10 和 IL-13 的水平,同时观察 R848 对其的影响。结果发现,除 III 组外,各组肝纤维化患者 SEA 刺激 PBMC 培养上清液中 IL-10 水平均显著升高,且 R848 可诱导升高;0 组和 I 组 IFN-γ水平显著升高,0 组 IL-4 水平显著降低。然而,R848 对 IL-13 无影响。这些结果表明,R848 可能作为一种免疫增强剂,用于曼氏血吸虫感染的新型治疗或疫苗。

相似文献

1
Immunomodulatory effect of R848 on cytokine production associated with Schistosoma mansoni infection.R848 对曼氏血吸虫感染相关细胞因子产生的免疫调节作用。
Parasitol Res. 2013 Jan;112(1):135-40. doi: 10.1007/s00436-012-3116-2. Epub 2012 Sep 20.
2
Association of IL-9, IL-10, and IL-17 Cytokines With Hepatic Fibrosis in Human Infection.白细胞介素-9、白细胞介素-10 和白细胞介素-17 细胞因子与人类感染相关的肝纤维化的关系。
Front Immunol. 2021 Dec 14;12:779534. doi: 10.3389/fimmu.2021.779534. eCollection 2021.
3
Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoni infection.2型细胞因子与人类曼氏血吸虫感染中肝纤维化的关联。
Infect Immun. 2004 Jun;72(6):3391-7. doi: 10.1128/IAI.72.6.3391-3397.2004.
4
Protective effects of Sm-p80 in the presence of resiquimod as an adjuvant against challenge infection with Schistosoma mansoni in mice.Sm-p80 与瑞喹莫德联合佐剂对曼氏血吸虫感染小鼠的保护作用。
Int J Infect Dis. 2010 Sep;14(9):e781-7. doi: 10.1016/j.ijid.2010.02.2266. Epub 2010 Jul 13.
5
Clinical and immunological consequences of human T cell leukemia virus type-I and Schistosoma mansoni co-infection.人类I型T细胞白血病病毒与曼氏血吸虫共同感染的临床和免疫后果
Mem Inst Oswaldo Cruz. 2004;99(5 Suppl 1):121-6. doi: 10.1590/s0074-02762004000900022. Epub 2004 Oct 13.
6
Cytokine production associated with periportal fibrosis during chronic schistosomiasis mansoni in humans.人类慢性曼氏血吸虫病期间与汇管区周围纤维化相关的细胞因子产生
Infect Immun. 2006 Feb;74(2):1215-21. doi: 10.1128/IAI.74.2.1215-1221.2006.
7
Repeated exposure induces periportal fibrosis in Schistosoma mansoni-infected baboons: role of TGF-beta and IL-4.反复暴露会在感染曼氏血吸虫的狒狒中诱导门周纤维化:转化生长因子-β和白细胞介素-4的作用
J Immunol. 2000 May 15;164(10):5337-43. doi: 10.4049/jimmunol.164.10.5337.
8
Cytokine profile associated with human chronic schistosomiasis mansoni.与人类慢性曼氏血吸虫病相关的细胞因子谱
Mem Inst Oswaldo Cruz. 2004;99(5 Suppl 1):21-6. doi: 10.1590/s0074-02762004000900004. Epub 2004 Oct 13.
9
Human peripheral blood mononuclear cells stimulated by Schistosoma mansoni antigens: association between protein tyrosine kinases, mitogen-activated protein kinases and cytokine production.曼氏血吸虫抗原刺激的人外周血单个核细胞:蛋白酪氨酸激酶、丝裂原活化蛋白激酶与细胞因子产生之间的关联
Parasitol Int. 2000 Jan;48(3):255-64. doi: 10.1016/s1383-5769(99)00027-6.
10
Human schistosomiasis mansoni: immune responses during acute and chronic phases of the infection.人类曼氏血吸虫病:感染急性期和慢性期的免疫反应。
Acta Trop. 2008 Nov-Dec;108(2-3):109-17. doi: 10.1016/j.actatropica.2008.05.027. Epub 2008 Jun 5.

引用本文的文献

1
The WHO ultrasonography protocol for assessing hepatic morbidity due to Schistosoma mansoni. Acceptance and evolution over 12 years.世界卫生组织用于评估曼氏血吸虫病所致肝脏病变的超声检查方案。12年来的接受情况及演变
Parasitol Res. 2014 Nov;113(11):3915-25. doi: 10.1007/s00436-014-4117-0. Epub 2014 Sep 27.
2
Delivery of host cell-directed therapeutics for intracellular pathogen clearance.针对细胞内病原体清除的宿主细胞导向治疗药物的递送。
Expert Rev Anti Infect Ther. 2013 Nov;11(11):1225-35. doi: 10.1586/14787210.2013.845524. Epub 2013 Oct 18.
3
Liposomal resiquimod for the treatment of Leishmania donovani infection.

本文引用的文献

1
Inflammatory cytokines IFN-γ, IL-4, IL-13 and TNF-α alterations in schistosomiasis: a meta-analysis.在血吸虫病中,干扰素-γ、IL-4、IL-13 和 TNF-α 等炎症细胞因子的变化:一项荟萃分析。
Parasitol Res. 2012 Apr;110(4):1547-52. doi: 10.1007/s00436-011-2661-4. Epub 2011 Oct 4.
2
IL-10 blocks the development of resistance to re-infection with Schistosoma mansoni.白细胞介素-10 可阻止对曼氏血吸虫再感染的抵抗力的发展。
PLoS Pathog. 2011 Aug;7(8):e1002171. doi: 10.1371/journal.ppat.1002171. Epub 2011 Aug 4.
3
Schistosoma mansoni population structure and persistence after praziquantel treatment in two villages of Bahia, Brazil.
脂质体瑞喹莫德治疗感染杜氏利什曼原虫。
J Antimicrob Chemother. 2014 Jan;69(1):168-75. doi: 10.1093/jac/dkt320. Epub 2013 Aug 16.
曼氏血吸虫在巴西巴伊亚州两个村庄经吡喹酮治疗后的种群结构和持续存在情况。
Int J Parasitol. 2011 Aug 15;41(10):1093-9. doi: 10.1016/j.ijpara.2011.06.002. Epub 2011 Jul 13.
4
Protective effects of Sm-p80 in the presence of resiquimod as an adjuvant against challenge infection with Schistosoma mansoni in mice.Sm-p80 与瑞喹莫德联合佐剂对曼氏血吸虫感染小鼠的保护作用。
Int J Infect Dis. 2010 Sep;14(9):e781-7. doi: 10.1016/j.ijid.2010.02.2266. Epub 2010 Jul 13.
5
Cytokine profile associated with chronic and acute human schistosomiasis mansoni.
Mem Inst Oswaldo Cruz. 2008 Sep;103(6):561-8. doi: 10.1590/s0074-02762008000600009.
6
Coinfection with the intestinal nematode Heligmosomoides polygyrus markedly reduces hepatic egg-induced immunopathology and proinflammatory cytokines in mouse models of severe schistosomiasis.在严重血吸虫病小鼠模型中,肠道线虫多房棘球绦虫的共感染显著降低了肝脏虫卵诱导的免疫病理学和促炎细胞因子水平。
Infect Immun. 2008 Nov;76(11):5164-72. doi: 10.1128/IAI.00673-08. Epub 2008 Aug 18.
7
TLR7/8 ligand, R-848, inhibits IgE synthesis by acting directly on B lymphocytes.Toll样受体7/8配体R-848通过直接作用于B淋巴细胞来抑制免疫球蛋白E的合成。
Scand J Immunol. 2008 Jun;67(6):560-8. doi: 10.1111/j.1365-3083.2008.02105.x. Epub 2008 Apr 4.
8
Experimental vaccines in animal models for schistosomiasis.用于血吸虫病的动物模型实验性疫苗
Parasitol Res. 2008 Apr;102(5):825-33. doi: 10.1007/s00436-008-0887-6. Epub 2008 Feb 8.
9
Resiquimod and other immune response modifiers as vaccine adjuvants.瑞喹莫德及其他免疫反应调节剂作为疫苗佐剂
Expert Rev Vaccines. 2007 Oct;6(5):835-47. doi: 10.1586/14760584.6.5.835.
10
Cytokine production associated with periportal fibrosis during chronic schistosomiasis mansoni in humans.人类慢性曼氏血吸虫病期间与汇管区周围纤维化相关的细胞因子产生
Infect Immun. 2006 Feb;74(2):1215-21. doi: 10.1128/IAI.74.2.1215-1221.2006.